Skip to content
10-Q

Quarterly Report

MJ Pharmaceuticals Inc.

0001185185-14-002826

← back to feed
Filed
Oct 28, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Sep 30, 2014 185.74M sh
Operating Cash Flow Q3 2014 · Sep 30, 2014 −$11.19K
Operating Cash Flow Q3 2014 · Sep 30, 2013 $0
Cash And Equivalents Q3 2014 · Sep 30, 2014 $7.39K
Cash And Equivalents Q3 2014 · Dec 31, 2013 $0
Cash And Equivalents Q3 2014 · Sep 30, 2013 $0
Cash And Equivalents Q3 2014 · Dec 31, 2012 $0
Stockholders Equity Q3 2014 · Sep 30, 2014 $6.83K
Stockholders Equity Q3 2014 · Dec 31, 2012 $0
Current Liabilities Q3 2014 · Sep 30, 2014 $45.84K
Current Liabilities Q3 2014 · Dec 31, 2013 $0
Current Assets Q3 2014 · Sep 30, 2014 $52.67K
Current Assets Q3 2014 · Dec 31, 2013 $0
Total Assets Q3 2014 · Sep 30, 2014 $52.67K
Total Assets Q3 2014 · Dec 31, 2013 $0
Net Income Q3 2014 · Sep 30, 2014 −$11.75K
Net Income Q3 2014 · Dec 31, 2013 −$850
Net Income Q3 2014 · Sep 30, 2013 $0
Net Income Q3 2014 · Sep 30, 2013 $0
Net Income Q3 2014 · Dec 31, 2012 −$3.14K
Gross Profit Q3 2014 · Sep 30, 2014 $1.37K
Gross Profit Q3 2014 · Sep 30, 2013 $0
Gross Profit Q3 2014 · Sep 30, 2013 $0
Eps Basic Q3 2014 · Sep 30, 2013 $0.00
Eps Basic Q3 2014 · Sep 30, 2013 $0.00